IR-MED
IR-MED Inc. is a healthcare technology company specializing in non-invasive, AI-driven diagnostic devices. Their mission is to improve patient care through innovative, real-time biomarker analysis at the point of care, addressing critical markets such as pressure injury detection, diabetic foot ulcer assessment, drug level monitoring, and pediatric ear infection detection. They focus on developing advanced infrared spectrography and AI analysis platforms to provide non-invasive, accurate, and accessible medical diagnostics.
Industries
Nr. of Employees
small (1-50)
IR-MED
Z.H.R Industrial Zone, P.O. Box 143, 20 Yahalom St. Rosh Pinna, Israel
Patents
Products
Handheld spectrographic device for pressure-related tissue injury assessment
Handheld point-of-care spectrographic device that acquires tissue spectral signatures and applies ML analysis to support early detection and assessment of pressure-related tissue injury across diverse skin tones; the device is in advanced development and undergoing usability and multicenter evaluations with reported performance metrics.
Handheld spectrographic device for diabetic foot ulcer risk assessment
Handheld point-of-care spectrographic device under development to analyze tissue and blood biomarkers associated with diabetic foot ulcer risk without invasive sampling.
Point-of-care infection triage application using spectral biomarkers
Application combining non-invasive optical biomarker sensing with ML analysis to assist differentiation between viral and bacterial infections for triage decisions.
Non-invasive continuous drug-level monitoring platform
Platform demonstrated to monitor drug concentrations non-invasively and continuously at the point of care; clinical proof-of-concept reported for procedural and anesthesia settings.
Handheld spectrographic device for pressure-related tissue injury assessment
Handheld point-of-care spectrographic device that acquires tissue spectral signatures and applies ML analysis to support early detection and assessment of pressure-related tissue injury across diverse skin tones; the device is in advanced development and undergoing usability and multicenter evaluations with reported performance metrics.
Handheld spectrographic device for diabetic foot ulcer risk assessment
Handheld point-of-care spectrographic device under development to analyze tissue and blood biomarkers associated with diabetic foot ulcer risk without invasive sampling.
Point-of-care infection triage application using spectral biomarkers
Application combining non-invasive optical biomarker sensing with ML analysis to assist differentiation between viral and bacterial infections for triage decisions.
Non-invasive continuous drug-level monitoring platform
Platform demonstrated to monitor drug concentrations non-invasively and continuously at the point of care; clinical proof-of-concept reported for procedural and anesthesia settings.
Services
Design and execution of pilot clinical studies, usability testing and multicenter evaluations to validate non-invasive point-of-care spectral devices and to collect diagnostic performance and outcome metrics.
Systems and product development services that integrate international quality standards, design controls, and cross-disciplinary engineering coordination for regulated medical devices.
Support for regulatory filing preparation including coordination of clinical and usability evidence and submission planning for U.S. regulatory authorities.
Design and execution of pilot clinical studies, usability testing and multicenter evaluations to validate non-invasive point-of-care spectral devices and to collect diagnostic performance and outcome metrics.
Systems and product development services that integrate international quality standards, design controls, and cross-disciplinary engineering coordination for regulated medical devices.
Support for regulatory filing preparation including coordination of clinical and usability evidence and submission planning for U.S. regulatory authorities.
Expertise Areas
- Optical and near-infrared spectroscopy for biomarker detection
- Electro-optics and miniaturized sensor engineering
- Embedded systems and real-time signal acquisition
- Machine learning for spectral diagnostics and decision support
Key Technologies
- Near-infrared spectroscopy
- Optical reflectance spectroscopy
- Miniature electro-optical emitters and sensors
- Spectral unmixing and chromophore quantification
News & Updates
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) — “IR-MED” or the “Company”) (OTCQB:IRME), will be presenting its proprietary technology that is being designed to detect early-stage Pressure Injuries (PI) at the Annual Conference of the National Pressure Injury Advisory Panel.
The company’s PressureSafe device is being designed to reduce healthcare disparity in pressure injury detection and treatment Rosh Pina, Israel, March 14, 2023 (GLOBE NEWSWIRE) — “IR-MED” or the “Company”) (OTCQB:IRME), will be presenting its proprietary technology that is being designed to detect early-stage Pressure Injuries (PI) at the Annual Conference of the National Pressure Injury Advisory Panel.